Standard BioTools to Announce Second Quarter 2026 Financial Results on August 5, 2026

Standard BioTools to Announce Second Quarter 2026 Financial Results on August 5, 2026

Standard BioTools Inc. (NASDAQ: LAB) today announced that it will publish its second quarter 2026 financial results on Wednesday, August 5, 2026, after U.S. market close.About Standard BioTools Inc.

Standard BioTools, Inc. (NASDAQ: LAB), is committed to setting the new standard in the life science tools industry through strategic consolidation, best-in-class operations and a world-class management team. The Company's established portfolio includes essential, standardized next-generation solutions designed to help biomedical researchers develop better therapeutics faster.

For Research Use Only. Not for use in diagnostic procedures.

Limited Use Label License and other terms may apply: standardbio.com/legal/terms-and-conditions/.
Patent and License Information: standardbio.com/legal/notices.

Trademarks: standardbio.com/legal/trademarks. Any other trademarks are the sole property of their respective owners. ©2026 Standard BioTools Inc. (f.k.a. Fluidigm Corporation). All rights reserved.

Standard BioTools products are provided for Research Use Only. Not for use in diagnostic procedures.

Investor Contact:
ir@standardbio.com


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

Standard BioToolsLABNGS:LABbiotech investing
LAB
The Conversation (0)
Corcel Drills Cu-Au Skarn, Indications of Nearby Porphyry Cu-Au Center at the Yuma King Project, Arizona

Corcel Drills Cu-Au Skarn, Indications of Nearby Porphyry Cu-Au Center at the Yuma King Project, Arizona

Corcel Exploration Inc. (CSE: CRCL,OTC:CRLEF) (OTCQB: CRLEF) (FSE: Y67) (the "Company" or "Corcel") is pleased to announce the final assay results from the recently completed Phase I drill program at the Yuma King Project (the "Project") located in west-central Arizona. The initial campaign... Keep Reading...
Nine Mile Metals Announces Certified Assays of 3.49% Cu-Eq over 24.55 meters in DDH WD-26-09

Nine Mile Metals Announces Certified Assays of 3.49% Cu-Eq over 24.55 meters in DDH WD-26-09

Including 4.03% Cu-Eq over 16.50m and 5.22% Cu-Eq over 6.50m Nine Mile Metals Ltd. (CSE: NINE,OTC:VMSXF) (OTCID: VMSXF) (FSE: KQ9) (the "Company" or "Nine Mile") is pleased to announce certified assay results for DDH WD-26-09, at the Wedge Mine in the Bathurst Mining Camp, New Brunswick. 3.49%... Keep Reading...
Cascadia Expands Mineralization at the Carmacks Project with 52.84 m of 1.04% Cu and 0.37 g/t Au

Cascadia Expands Mineralization at the Carmacks Project with 52.84 m of 1.04% Cu and 0.37 g/t Au

Cascadia Minerals Ltd. ("Cascadia") (TSXV: CAM,OTC:CAMNF) (OTCQB: CAMNF) is pleased to announce the results of six additional drill holes from its fully-funded 2026 exploration program at the road-accessible Carmacks copper-gold project in central Yukon. These results continue to expand... Keep Reading...
Lahontan Drills 12.2m Grading 1.25 g/t Au Oxide at Calvada East

Lahontan Drills 12.2m Grading 1.25 g/t Au Oxide at Calvada East

Lahontan Gold Corp. (TSXV:LG,OTC:LGCXF, OTCQB:LGCXF, FSE:Y2F) (the "Company" or "Lahontan") is pleased to announce additional drill results from its 2026 drilling program at the Santa Fe Mine Project. The results reported herein comprise seven reverse-circulation ("RC") drill holes totaling... Keep Reading...
Pinnacle Reopens Additional Historic Mine Workings at El Potrero and Samples up to 26.1 g/t Au and 511 g/t Ag

Pinnacle Reopens Additional Historic Mine Workings at El Potrero and Samples up to 26.1 g/t Au and 511 g/t Ag

(TheNewswire) VANCOUVER, BRITISH COLUMBIA TheNewswire - August 4, 2026 (TSXV: PINN,OTC:PSGCF, OTCQB: PSGCF, Frankfurt: P9J) Pinnacle Silver and Gold Corp. ("Pinnacle" or the "Company") is pleased to announce that, during the rehabilitation and drill station preparation in the historic... Keep Reading...
Person in blue scrubs interacts with a digital interface featuring graphs and medical icons.

Biotech and Pharma Market Trends: Q2 2026 Review and Forecast

Biotech is starting to edge back into focus as investors reassess the durability of the artificial intelligence (AI) trade and look for sectors where AI is producing tangible operational gains. “There are concerns that we’re in an AI bubble, and I think money is starting to go from companies... Keep Reading...
Row of test tubes and pipette with chemical droplet chemical coming from it.

Top 5 Small-cap Biotech Stocks in 2026

The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) has climbed back to multi-year highs in 2026, underscoring renewed strength in the biotech sector despite broader market volatility. As of July 7, the index stood at 6,856.74, up over 20 percent year-to-date. The rise shows that investors are... Keep Reading...
Lexaria Updates Business Development

Lexaria Updates Business Development

(TheNewswire) Kelowna, British Columbia July 6, 2026 TheNewswire Lexaria Bioscience Corp. (Nasdaq: LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to have experienced many positive meetings with potential pharmaceutical partners and collaborators at... Keep Reading...
Lexaria Updates Business Development

Lexaria Updates Business Development

KELOWNA, BC / ACCESS Newswire / July 6, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to have experienced many positive meetings with potential pharmaceutical partners and collaborators at the 2026 BIO... Keep Reading...
Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule

Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule

KELOWNA, BC / ACCESS Newswire / June 25, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that dosing began on schedule on June 14th with Human Pilot Study #7 (GLP-1-H26-7) that is evaluating two oral... Keep Reading...
Lexaria's Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule

Lexaria's Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule

Potentially Valuable Novel Compositions Being InvestigatedLexaria Also Receives Additional New Granted Patent KELOWNA, BC / ACCESS Newswire / June 23, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, provides the following... Keep Reading...

Latest News

More News

Interactive Chart

Latest Press Releases

Magnetic Surveys Completed across Swedish Cu-Au Portfolio

Drilling Commencing at Feather Cap

New Found Gold Files Second Quarter 2026 Financial Statements

MAYFAIR GOLD REPORTS Q2 2026 OPERATING AND FINANCIAL RESULTS

Related News

agriculture investing

Magnetic Surveys Completed across Swedish Cu-Au Portfolio

base metals investing

Drilling Commencing at Feather Cap

precious metals investing

New Found Gold Files Second Quarter 2026 Financial Statements

precious metals investing

MAYFAIR GOLD REPORTS Q2 2026 OPERATING AND FINANCIAL RESULTS

rare earth investing

Energy Fuels Secures Shareholder Votes for ASM Acquisition

oil and gas investing

Kojo Orgle: Why Investors Shouldn't Ignore Oil Market Fundamentals

oil and gas investing

Potential Oil & Gas Drilling Contractors Assess Drill Sites with Enercam Management on Block VIII, Cambodia